Literature DB >> 22783592

Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level.

Waldemar Rozanski1, Anna Krzeslak, Ewa Forma, Magdalena Brys, Mariusz Blewniewski, Paweł Wozniak, Marek Lipinski.   

Abstract

BACKGROUND: The mRNA expression of genes coding enzymes involved in O-GlcNAcylation were analyzed in urine obtained from 176 bladder cancer (BC) patients and 143 healthy persons.
METHODS: MGEA5 and OGT expression was measured by a real-time PCR assay.
RESULTS: OGT expression was not detected in urine of healthy persons but it was found in 51.7% of BC samples. Positive expression of MGEA5 was found in urine of both healthy persons (47.1%) and BC patients (52.3%). Poorly differentiated BC (grade III) showed significantly lower MGEA5 expression than grade I tumors. Contrary, OGT transcript level was significantly higher in grade II and III in comparison to grade I BC. Moreover, there was significant difference in OGT expression between early bladder cancers and invasive or advanced bladder cancers.
CONCLUSIONS: These results suggest that analysis of urinary content of MGEA5 and OGT may be useful for bladder cancer diagnostics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783592

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  34 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

2.  mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

Authors:  Valerie L Sodi; Sakina Khaku; Raisa Krutilina; Luciana P Schwab; David J Vocadlo; Tiffany N Seagroves; Mauricio J Reginato
Journal:  Mol Cancer Res       Date:  2015-01-30       Impact factor: 5.852

Review 3.  O-GlcNAc signaling in cancer metabolism and epigenetics.

Authors:  Jay Prakash Singh; Kaisi Zhang; Jing Wu; Xiaoyong Yang
Journal:  Cancer Lett       Date:  2014-04-24       Impact factor: 8.679

Review 4.  Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.

Authors:  Zhiyuan Ma; Keith Vosseller
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 5.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

Review 6.  O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.

Authors:  Christina M Ferrer; Valerie L Sodi; Mauricio J Reginato
Journal:  J Mol Biol       Date:  2016-06-23       Impact factor: 5.469

7.  Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway.

Authors:  Bing Zhang; Panpan Zhou; Xue Li; Qing Shi; Dong Li; Xiuli Ju
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

Review 8.  Cracking the O-GlcNAc code in metabolism.

Authors:  Hai-Bin Ruan; Jay Prakash Singh; Min-Dian Li; Jing Wu; Xiaoyong Yang
Journal:  Trends Endocrinol Metab       Date:  2013-05-04       Impact factor: 12.015

Review 9.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

10.  Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.

Authors:  Katarzyna Starska; Ewa Forma; Ewa Brzezińska-Błaszczyk; Iwona Lewy-Trenda; Magdalena Bryś; Paweł Jóźwiak; Anna Krześlak
Journal:  Clin Exp Med       Date:  2014-10-15       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.